These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 17624922

  • 41. The evaluation of the local tolerance of vaginal formulations, with or without nonoxynol-9, using the slug mucosal irritation test.
    Dhondt MM, Adriaens E, Remon JP.
    Sex Transm Dis; 2004 Apr; 31(4):229-35. PubMed ID: 15028937
    [Abstract] [Full Text] [Related]

  • 42. Contraceptive efficacy and safety studies of a novel microemulsion-based lipophilic vaginal spermicide.
    D'Cruz OJ, Yiv SH, Waurzyniak B, Uckun FM.
    Fertil Steril; 2001 Jan; 75(1):115-24. PubMed ID: 11163825
    [Abstract] [Full Text] [Related]

  • 43. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G.
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [Abstract] [Full Text] [Related]

  • 44. PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity.
    Keller MJ, Guzman E, Hazrati E, Kasowitz A, Cheshenko N, Wallenstein S, Cole AL, Cole AM, Profy AT, Wira CR, Hogarty K, Herold BC.
    AIDS; 2007 Feb 19; 21(4):467-76. PubMed ID: 17301565
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
    Keller MJ, Carpenter CA, Lo Y, Einstein MH, Liu C, Fredricks DN, Herold BC.
    PLoS One; 2012 Feb 19; 7(10):e46901. PubMed ID: 23056520
    [Abstract] [Full Text] [Related]

  • 48. Development of an in vitro alternative assay method for vaginal irritation.
    Ayehunie S, Cannon C, Larosa K, Pudney J, Anderson DJ, Klausner M.
    Toxicology; 2011 Jan 11; 279(1-3):130-8. PubMed ID: 20937349
    [Abstract] [Full Text] [Related]

  • 49. Antileukemic activity and cellular metabolism of the aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07).
    Uckun FM, Tai HL, D'Cruz OJ.
    Arzneimittelforschung; 2005 Jan 11; 55(1):50-65. PubMed ID: 15727164
    [Abstract] [Full Text] [Related]

  • 50. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC.
    J Infect Dis; 2007 May 01; 195(9):1332-9. PubMed ID: 17397004
    [Abstract] [Full Text] [Related]

  • 51. Evaluation of a vaginal moisturizer in baboons with decreasing ovarian function.
    Hubbard GB, Carey KD, Levine H, Bachmann GA.
    Lab Anim Sci; 1997 Feb 01; 47(1):36-9. PubMed ID: 9051645
    [Abstract] [Full Text] [Related]

  • 52. Test of new vaginal microbicide gel show promise for women.
    AIDS Read; 2008 Apr 01; 18(4):165-6. PubMed ID: 18467997
    [No Abstract] [Full Text] [Related]

  • 53. Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles.
    D'Cruz OJ, Uckun FM.
    Contraception; 2001 Aug 01; 64(2):113-23. PubMed ID: 11704088
    [Abstract] [Full Text] [Related]

  • 54. Safety studies of sperm agglutinating factor produced by Staphylococcus aureus as a vaginal contraceptive: in vivo studies.
    Kaur S, Prabha V, Kaur K.
    Gynecol Endocrinol; 2011 Nov 01; 27(11):956-60. PubMed ID: 21500995
    [Abstract] [Full Text] [Related]

  • 55. [Contraceptive efficacy of bioadhesive benzalkonium chloride gel in comparison with nonoxynol-9 gel].
    Xu JX, Huang ZR, Wu Y, Wang HY, Zhou XB, Xiao ZQ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct 01; 41(10):706-9. PubMed ID: 17199929
    [Abstract] [Full Text] [Related]

  • 56. Differential cytokine expression in skin after single and repeated irritation by sodium lauryl sulphate.
    de Jongh CM, Lutter R, Verberk MM, Kezic S.
    Exp Dermatol; 2007 Dec 01; 16(12):1032-40. PubMed ID: 18031463
    [Abstract] [Full Text] [Related]

  • 57. Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1.
    D'Cruz OJ, Uckun FM.
    Fertil Steril; 2007 Oct 01; 88(4 Suppl):1197-206. PubMed ID: 17498709
    [Abstract] [Full Text] [Related]

  • 58. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S.
    Contraception; 2008 Feb 01; 77(2):122-9. PubMed ID: 18226677
    [Abstract] [Full Text] [Related]

  • 59. No increase in cervicovaginal proinflammatory cytokines after Carraguard use in a placebo-controlled randomized clinical trial.
    Bollen LJ, Blanchard K, Kilmarx PH, Chaikummao S, Connolly C, Wasinrapee P, Srivirojana N, Achalapong J, Tappero JW, McNicholl JM.
    J Acquir Immune Defic Syndr; 2008 Feb 01; 47(2):253-7. PubMed ID: 18025996
    [Abstract] [Full Text] [Related]

  • 60. A quantitative multiplex nuclease protection assay reveals immunotoxicity gene expression profiles in the rabbit model for vaginal drug safety evaluation.
    Fichorova RN, Mendonca K, Yamamoto HS, Murray R, Chandra N, Doncel GF.
    Toxicol Appl Pharmacol; 2015 Jun 15; 285(3):198-206. PubMed ID: 25818602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.